A 65-year-old patient with chronic kidney disease is found to have a deficiency of
antithrombin III after he presented to emergency department with left leg pain and
swelling.
A doppler-ultrasound scan of the leg confirms deep venous thrombosis (DVT). The
patient is started on dabigatran.
What is the mechanism of action of dabigat ran?
Activates anti -thrombin III
P2Y12 inhibitor
Glycoprotein lib/Ilia inhibitor
Direct th rombin inhib itor
Direct factor X activator
#فارما
#blood
antithrombin III after he presented to emergency department with left leg pain and
swelling.
A doppler-ultrasound scan of the leg confirms deep venous thrombosis (DVT). The
patient is started on dabigatran.
What is the mechanism of action of dabigat ran?
Activates anti -thrombin III
P2Y12 inhibitor
Glycoprotein lib/Ilia inhibitor
Direct th rombin inhib itor
Direct factor X activator
#فارما
#blood
Dabigatran is a direct thrombin inhibitor
Below is a table of the drugs and their mechanisms of actions (MOA):
Drug name MOA
Heparin activates anti-thrombin III
Clopidogrel P2Y12 inhibitor
Abciximab glycoprotein lib/lila inhibitor
Dabigatran direct thrombin inhibitor
Rivaroxaban direct factor X inhibitor
#فارما
#blood
Below is a table of the drugs and their mechanisms of actions (MOA):
Drug name MOA
Heparin activates anti-thrombin III
Clopidogrel P2Y12 inhibitor
Abciximab glycoprotein lib/lila inhibitor
Dabigatran direct thrombin inhibitor
Rivaroxaban direct factor X inhibitor
#فارما
#blood
Forwarded from SHADDAD'S Summaries
Forwarded from SHADDAD'S Summaries